The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
IU Simon Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center is the central hub for cancer research and education across Indiana University. Over the last three decades, its far-reaching discoveries have changed the way cancer is treated around the world. The center’s recent advances in genomics, immunotherapy, bioinformatics, and other sciences are transforming knowledge about cancer prevention, screening, diagnosis and survivorship.
Showing results for IU Simon Comprehensive Cancer Center
Two researchers with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the Richard L. Roudebush Veterans Administration Medical Center have been awarded a three-year, $1 million grant to expand lung cancer screenings to veterans across Indiana.
More students than ever will be able to participate in meaningful cancer-focused research experiences through summer programs at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, thanks to two new five-year grants from the National Cancer Institute.
An Indiana University leukemia physician-scientist has been awarded a $1 million grant from the Leukemia and Lymphoma Society to evaluate a new treatment for an extremely rare and incurable blood cancer.
Two researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have received a five-year, $2.4 million grant from the National Cancer Institute (NCI) to explore new therapies that target the critical pathways pancreatic tumors use to survive.
A mobile lung cancer screening program will soon take life-saving screenings to eligible high-risk Hoosiers statewide, thanks to a generous $4.5 million gift from the Tom and Julie Wood Family Foundation that will include matching dollars from Indiana University Health, bringing its impact to $8.5 million.
A breast cancer researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.2 million grant from the National Cancer Institute to examine how certain immune cells support metastatic breast cancer development—and how to stop it.